ADAR1 Capital Management »

NCR Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of NCR Corporation (VYX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in NCR Corporation

Tip: Access up to 7 years of quarterly data

All positions including NCR Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NCR Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $25k 2.0k 12.63
2023-12-31 $34k 2.0k 16.91

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding NCR Corporation

BlackRock
BlackRock
Vanguard Group
Shapiro Capital Management
Greenhouse Funds L
Engaged Capital
Hanna Zanoni
State Street Corporation
Victory Capital Management
Brown Advisory Holdings Incorporated
First Pacific Advisors
Geode Capital Management
Philosophy Capital Management
Dimensional Fund Advisors
Morgan Stanley

View all funds holding NCR Corporation